AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
MAINTENANCE PHASE EFFICACY OF SERTRALINE FOR CHRONIC DEPRESSION - A RANDOMIZED CONTROLLED TRIAL
Authors: KELLER MB KOCSIS JH THASE ME GELENBERG AJ RUSH AJ KORAN L SCHATZBERG A RUSSELL J HIRSCHFELD R KLEIN D MCCULLOUGH JP FAWCETT JA KORNSTEIN S LAVANGE L HARRISON W
Citation: Mb. Keller et al., MAINTENANCE PHASE EFFICACY OF SERTRALINE FOR CHRONIC DEPRESSION - A RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 280(19), 1998, pp. 1665-1672
NEW DRUGS, OLD DILEMMAS
Authors: GELENBERG AJ
Citation: Aj. Gelenberg, NEW DRUGS, OLD DILEMMAS, Psychiatric annals, 28(3), 1998, pp. 115-115
MIRTAZAPINE SUBSTITUTION IN SSRI-INDUCED SEXUAL DYSFUNCTION
Authors: GELENBERG AJ LAUKES C MCGAHUEY C OKAYLI G MORENO FA BOLOGNA L DELGADO PL
Citation: Aj. Gelenberg et al., MIRTAZAPINE SUBSTITUTION IN SSRI-INDUCED SEXUAL DYSFUNCTION, Biological psychiatry, 43, 1998, pp. 345-345
SEQUENTIAL CATECHOLAMINE AND 5-HT DEPLETION IN MIRTAZAPINE-TREATED DEPRESSION
Authors: DELGADO PL MORENO FA GELENBERG AJ POTTER R
Citation: Pl. Delgado et al., SEQUENTIAL CATECHOLAMINE AND 5-HT DEPLETION IN MIRTAZAPINE-TREATED DEPRESSION, Biological psychiatry, 43, 1998, pp. 346-346
GUIDELINES FOR ASSESSING THE DECISION-MAKING CAPACITIES OF POTENTIAL RESEARCH SUBJECTS WITH COGNITIVE IMPAIRMENT
Authors: BINDER RL GUZE SB APPELBAUM PS LIEBERMAN JA RABINS PV OLDHAM JM BLACKER DL GELENBERG AJ RECUPERO PR OLSON DP PINCUS HA ZARIN DA FERRIS S
Citation: Rl. Binder et al., GUIDELINES FOR ASSESSING THE DECISION-MAKING CAPACITIES OF POTENTIAL RESEARCH SUBJECTS WITH COGNITIVE IMPAIRMENT, The American journal of psychiatry, 155(11), 1998, pp. 1649-1650
KNOWING OUR LIMITS
Authors: GELENBERG AJ
Citation: Aj. Gelenberg, KNOWING OUR LIMITS, Acta psychiatrica Scandinavica, 98(4), 1998, pp. 261-261
PINDOLOL AUGMENTATION OF TREATMENT-RESISTANT DEPRESSED-PATIENTS
Authors: MORENO FA GELENBERG AJ BACHAR K DELGADO PL
Citation: Fa. Moreno et al., PINDOLOL AUGMENTATION OF TREATMENT-RESISTANT DEPRESSED-PATIENTS, The Journal of clinical psychiatry, 58(10), 1997, pp. 437-439
SERTRALINE MAINTENANCE THERAPY IN CHRONIC DEPRESSION
Authors: THASE ME KELLER MB GELENBERG AJ HIRSCHFELD RMA SCHATZBERG AF KOCSIS J KLEIN D MCCULLOUGH JP FAWCETT J RUSH AJ HARRISON WM
Citation: Me. Thase et al., SERTRALINE MAINTENANCE THERAPY IN CHRONIC DEPRESSION, Psychopharmacology bulletin, 33(3), 1997, pp. 482-482
SERTRALINE VERSUS IMIPRAMINE IN THE TREATMENT OF CHRONIC DEPRESSION -EFFECTS OF ANTIDEPRESSANT PLASMA-CONCENTRATIONS
Authors: GELENBERG AJ TRAPP G DIBATTISTA C SOLOMON D VERNE D LAVANGE L HARRISON W
Citation: Aj. Gelenberg et al., SERTRALINE VERSUS IMIPRAMINE IN THE TREATMENT OF CHRONIC DEPRESSION -EFFECTS OF ANTIDEPRESSANT PLASMA-CONCENTRATIONS, Biological psychiatry, 41, 1997, pp. 329-329
COUNTERPOINT - PSYCHOPHARMACOLOGY SUPERVISION
Authors: GELENBERG AJ
Citation: Aj. Gelenberg, COUNTERPOINT - PSYCHOPHARMACOLOGY SUPERVISION, Academic psychiatry, 20(4), 1996, pp. 241-241
ANTIPSYCHOTICS IN BIPOLAR DISORDER
Authors: GELENBERG AJ HOPKINS HS
Citation: Aj. Gelenberg et Hs. Hopkins, ANTIPSYCHOTICS IN BIPOLAR DISORDER, The Journal of clinical psychiatry, 57, 1996, pp. 49-52
STANDING GUARD
Authors: GELENBERG AJ
Citation: Aj. Gelenberg, STANDING GUARD, The Journal of clinical psychiatry, 57(12), 1996, pp. 564-566
ANNUAL APPRECIATION
Authors: GELENBERG AJ
Citation: Aj. Gelenberg, ANNUAL APPRECIATION, The Journal of clinical psychiatry, 57(1), 1996, pp. 5-6
PINDOLOL AUGMENTATION IN TREATMENT-RESISTANT DEPRESSED-PATIENTS
Authors: MORENO FA DELGADO PL BACHAR K GELENBERG AJ
Citation: Fa. Moreno et al., PINDOLOL AUGMENTATION IN TREATMENT-RESISTANT DEPRESSED-PATIENTS, Psychopharmacology bulletin, 32(3), 1996, pp. 492-492
SERUM LITHIUM LEVELS AND PSYCHOSOCIAL FUNCTION IN PATIENTS WITH BIPOLAR-I-DISORDER
Authors: SOLOMON DA RISTOW WR KELLER MB KANE JM GELENBERG AJ ROSENBAUM JF WARSHAW MG
Citation: Da. Solomon et al., SERUM LITHIUM LEVELS AND PSYCHOSOCIAL FUNCTION IN PATIENTS WITH BIPOLAR-I-DISORDER, The American journal of psychiatry, 153(10), 1996, pp. 1301-1307
POLYPHARMACY IN PSYCHIATRY - BALANCING CAUTION WITH DARING
Authors: GELENBERG AJ
Citation: Aj. Gelenberg, POLYPHARMACY IN PSYCHIATRY - BALANCING CAUTION WITH DARING, CNS DRUGS, 4(6), 1995, pp. 410-411
THE HIGH COST OF BUSPIRONE - REPLY
Authors: GELENBERG AJ
Citation: Aj. Gelenberg, THE HIGH COST OF BUSPIRONE - REPLY, The Journal of clinical psychiatry, 56(8), 1995, pp. 376-376
LITHIUM TREMOR
Authors: GELENBERG AJ JEFFERSON JW
Citation: Aj. Gelenberg et Jw. Jefferson, LITHIUM TREMOR, The Journal of clinical psychiatry, 56(7), 1995, pp. 283-287
DUPLICATE PUBLICATION
Authors: GELENBERG AJ OTTOSSON JO
Citation: Aj. Gelenberg et Jo. Ottosson, DUPLICATE PUBLICATION, The Journal of clinical psychiatry, 56(2), 1995, pp. 81-81
THREATS AND PROMISES
Authors: GELENBERG AJ
Citation: Aj. Gelenberg, THREATS AND PROMISES, The Journal of clinical psychiatry, 56(10), 1995, pp. 448-449
FLUOXETINE AND SEXUAL DYSFUNCTION
Authors: HOPKINS HS GELENBERG AJ
Citation: Hs. Hopkins et Aj. Gelenberg, FLUOXETINE AND SEXUAL DYSFUNCTION, JAMA, the journal of the American Medical Association, 273(19), 1995, pp. 1489-1490
UNTITLED
Authors: GELENBERG AJ OTTOSSON JO
Citation: Aj. Gelenberg et Jo. Ottosson, UNTITLED, Acta psychiatrica Scandinavica, 91(3), 1995, pp. 145-145
FLUOXETINE IN DEMENTIA OF THE ALZHEIMER-TYPE - PROMINENT ADVERSE-EFFECTS AND FAILURE TO IMPROVE COGNITION
Authors: GELENBERG AJ
Citation: Aj. Gelenberg, FLUOXETINE IN DEMENTIA OF THE ALZHEIMER-TYPE - PROMINENT ADVERSE-EFFECTS AND FAILURE TO IMPROVE COGNITION, The Journal of clinical psychiatry, 55(4), 1994, pp. 163-163
MAJOR COMPLICATIONS OF NEUROLEPTIC DRUG-USE
Authors: GELENBERG AJ
Citation: Aj. Gelenberg, MAJOR COMPLICATIONS OF NEUROLEPTIC DRUG-USE, Western journal of medicine, 160(1), 1994, pp. 55-56
TREATMENT OF BIPOLAR DISORDER - HOW FAR HAVE WE COME
Authors: HOPKINS HS GELENBERG AJ
Citation: Hs. Hopkins et Aj. Gelenberg, TREATMENT OF BIPOLAR DISORDER - HOW FAR HAVE WE COME, Psychopharmacology bulletin, 30(1), 1994, pp. 27-38
Risultati: 1-25 | 26-32